Clinical Trials Browser

Phase 1/2 × talazoparib × Other hematologic neoplasm × Clear all

NCT05319249 2024-04-05

NAKIP-AML

Phase 1/2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02878785 2023-03-29

1565GCC

Phase 1/2 Completed

25 enrolled 6 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute